FDA Inspection 599120 — Takeda Pharmaceutical Company Limited

Takeda Pharmaceutical Company Limited — FEI 3006611178

The FDA completed an inspection of Takeda Pharmaceutical Company Limited on June 11, 2009 in Ammon, ID. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 11, 2009
Fiscal Year
2009
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Ammon, ID (United States)

Citations

IDCFRDescription
15421 CFR 606.160(a)(1)Concurrent documentation